Federal contractor · public award history
LOCUS BIOSCIENCES INC
DBA LOCUS BIOSCIENCES INC
Parent: LOCUS BIOSCIENCES INC Unique Entity Identifier (UEI)CJKVLKZGX6F3
- Awards we know about
- 2
- Typical size
- $38.60M
- Middle of their public awards
- Dollars on those awards
- $77.20M
Most of their awards we can see fall roughly between $20.96M and $56.24M.
SAM.gov registration
- Status
- Active
- Purpose of registration
- All awards (Z2)
- Registration expires
- Jan 2, 2027
- Activation date
- Jan 6, 2026
- Primary NAICS (SAM)
- Research and Development in Biotechnology (except Nanobiotechnology)541714
Other NAICS on file
Business types (SAM)
Registration fields from the official SAM.gov public entity extract (monthly bulk). Not a substitute for live SAM checks.
Continue contractor research
Use the verified identifiers and public award record to investigate documented incumbents, compare competitors, or identify possible teaming partners. This is a research starting point, not a capability or partner recommendation.
These official USAspending contract records do not rate capability or past performance and do not tell you whether to team or bid.
Awarding agencies
- Department of Health and Human Services (2)
Industries & product codes
Award history
- Department of Health and Human Services$3.32MSep 22, 2025Procurement Instrument Identifier (PIID)75N93025C00035Research and Development in Biotechnology (except Nanobiotechnology)541714Health R&D Services; Health Care Services; Applied ResearchAN12Contract awardUSAspending ↗
ADVANCE A NOVEL THERAPEUTIC TO A FIRST-IN-HUMAN CLINICAL STUDY
- Department of Health and Human Services$73.89MSep 16, 2025Procurement Instrument Identifier (PIID)75A50120C00169Research and Development in Biotechnology (except Nanobiotechnology)541714Health R&D Services; Health Care Services; Experimental DevelopmentAN13Contract awardUSAspending ↗
CLINICAL DEVELOPMENT OF CRISPR-CAS3 PHAGE COCKTAIL FOR THE TREATMENT OF RECURRENT URINARY TRACT INFECTIONS CAUSED BY ESCHERICHIA COLI INCLUDING ANTIMICROBIAL AND MULTI-DRUG RESISTANT STRAINS
For research only. This is not legal advice, a past-performance review, or a recommendation to team or bid. Check USAspending and SAM.gov.